The REIT sector has taken it on the chin for nearly three years because of surging interest rates and high inflation.
Despite these challenges, income investors can still rely on this asset class to deliver dependable distributions through good times and bad.
Several REITs have demonstrated resilience amid the headwinds as they possess certain attributes that allow them to weather the storm.
Here are three Singapore REITs that will allow you to sleep well at night.
Keppel DC REIT is a data centre REIT with a portfolio of 25 data centres across 10 countries.
The REIT’s assets under management (AUM) stood at around S$5 billion as of 31 December 2024.
The data centre REIT reported a resilient set of earnings for 2024 despite the macroeconomic headwinds.
Gross revenue rose 10.3% year on year to S$310.3 million while net property income (NPI) improved by 6.3% year on year to S$260.3 million.
Distribution per unit (DPU) inched up 0.7% year on year to S$0.09451.
Keppel DC REIT also has a strong sponsor in blue-chip asset manager Keppel Ltd.
The REIT acquired two data centres from its sponsor last November, in an accretive transaction that should enable DPU to rise further.
Even without acquisitions, Keppel DC REIT boasted a strong positive rental reversion of ~39% for 2024, underscoring the strong demand for its assets.
Meanwhile, the data centre REIT also enjoyed a high portfolio occupancy of 97.1% along with a long portfolio weighted average lease expiry (WALE) of 6.3 years.
Management believes that data centres will continue to power the artificial intelligence $(AI)$ revolution, with the Asia-Pacific region experiencing a record high in data centre demand.
CapitaLand Ascendas REIT, or CLAR, is Singapore’s oldest and largest industrial REIT.
CLAR’s portfolio comprises 229 properties across Singapore, Australia, Europe, the US, and the UK.
These properties were valued at S$16.8 billion as of 31 December 2024.
Like Keppel DC REIT, CLAR also has a strong sponsor in CapitaLand Investment Limited, a blue-chip real estate investment manager with S$134 billion of AUM and S$102 billion of funds under management as of 30 September 2024.
The industrial REIT pulled off an admirable performance for 2024 with gross revenue inching up 2.9% year on year to S$1.5 billion.
NPI increased by 2.6% year on year to S$1 billion and DPU crept up 0.3% year on year to S$0.15205.
CLAR has a high-quality portfolio of properties that enjoyed a healthy occupancy of 92.8% at the end of 2024.
This portfolio also registered a positive rental reversion of 11.6% for the year.
CLAR’s manager is active in acquisitions and capital recycling.
Last year, the REIT conducted two acquisitions in the US for a total of S$248.2 million.
Elsewhere, CLAR also has eight asset enhancement initiatives in the works, at a total estimated cost of S$803.6 million.
Parkway Life REIT, or PLife REIT, is a healthcare REIT with a portfolio of 75 properties across Singapore, Japan, and France.
The REIT’s portfolio value stood at S$2.46 billion as of 31 December 2024.
Like the two REITs above, PLife REIT also has a strong sponsor in IHH Healthcare Berhad, an integrated healthcare player with hospitals across Singapore, Malaysia, and Turkey.
The healthcare REIT reported an admirable performance for 2024.
Gross revenue and NPI fell by 1.5% and 1.8% year on year, respectively, because of the weaker Japanese Yen.
However, DPU continued its climb, rising 1% year on year to S$0.1492 for 2024.
PLife REIT has racked up an impressive, uninterrupted core DPU growth since its IPO back in 2007.
The REIT also enjoys a long WALE of 15.34 years and 90.7% of its leases have downside protection.
Late last year, PLife REIT announced the acquisition of 11 nursing homes in France for €112 million, representing the REIT’s foray into a third key market.
This acquisition should help to boost its DPU moving forward and help diversify its portfolio further.
The REIT’s Singapore portfolio should also see a 24.4% year-on-year rental income jump in 2026 as part of the renegotiated master leases that were renewed back in 2022.
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。